Lake Street Initiates Coverage On Monopar Therapeutics with Buy Rating, Announces Price Target of $106
Benzinga Newsdesk 1 year ago
NewsPrice TargetInitiationAnalyst Ratings
Lake Street initiates coverage on Monopar Therapeutics (NASDAQ:MNPR) with a Buy rating and announces Price Target of $106.
Lake Street initiates coverage on Monopar Therapeutics (NASDAQ:MNPR) with a Buy rating and announces Price Target of $106.